Healthcare, biotechnology & medical AI Product
Heartvue.Proton quantifies structure and function on cardiac MRI
Heartvue.Proton processes acquired cardiac MRI studies and presents measurements and images for clinician review. The FDA filing covers the named software’s quantitative analysis of the heart and blood vessels. [1]
- Release status
- U.S. FDA 510(k) clearance K260811. [1]
What it does
The FDA cleared Heartvue.Proton on August 26, 2026, under K260811 as a Class II medical image management and processing system. [1]
Why it matters
The documented role is to provide measurements from MRI that clinicians can review and edit. Those measurements support interpretation of structure and function. [1]
Who it’s for
The indication addresses responsible clinicians assessing the specified cardiovascular MRI studies. [1]
Key dates
- FDA clears Heartvue.Proton [1]
Where it fits
The output includes processed images and calculated cardiac measurements. The software does not acquire images directly. [1]
Limits and trade-offs
The FDA indication assigns the measurements a supporting role in professional interpretation. The decision does not date a commercial rollout. [1]
Sources and verification
Catalog evidence checked How we verify records
- Primary source FDA 510(k) K260811 Heartvue.Proton
- Independent source FDA Clears AI-Powered Cardiac MRI Analysis Platform | Medical Product Outsourcing
Related profiles
Healthcare, biotechnology & medical AI
Sleep Analysis Module (SAM)
Neurotronics (Nihon Kohden)
The module estimates sleep time from a signal captured during its intended sleep-testing workflow.
Healthcare, biotechnology & medical AI
ThinkSono Guidance
ThinkSono
Provides guidance during acquisition of lower-extremity compression ultrasound images for review by healthcare professionals.
Healthcare, biotechnology & medical AI
Methinks Stroke suite
Methinks AI
Provides radiology triage and notification software, with separate FDA decisions for Methinks NCCT Stroke and CTA Stroke.